World's Best Scientists 2026 revealed!
Hubert Schrezenmeier

Hubert Schrezenmeier

D-Index & Metrics

Immunology

D-Index
92
Citations
30017
World Ranking
1007
National Ranking
62

Medicine

D-Index
92
Citations
30092
World Ranking
11339
National Ranking
613

Hubert Schrezenmeier publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Hubert Schrezenmeier sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 507 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Hubert Schrezenmeier D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Hubert Schrezenmeier sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 92 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Hubert Schrezenmeier is affiliated with the University of Ulm in Germany. Their research primarily focuses on the fields of Medicine and Immunology and Microbiology, with a substantial number of publications in these areas. Subfields of particular interest include Infectious Diseases, Immunology, Hematology, Genetics, and Nephrology.

The scientist's work covers a range of topics, notably:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Complement system in diseases
  • Renal Diseases and Glomerulopathies
  • Blood groups and transfusion
  • Hematopoietic Stem Cell Transplantation
  • T-cell and B-cell Immunology

Recent publications demonstrate active contributions to COVID-19-related immunology and hematology. Selected papers include:

  • "SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies" (2021, Cell)
  • "Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients" (2021, Science Immunology)
  • "Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients" (2021, Journal of Clinical Investigation)
  • "Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants" (2021, EBioMedicine)
  • "Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry" (2020, Annals of Hematology)

They frequently publish in specific venues, including:

  • Blood
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • Transfusionsmedizin
  • Journal of Clinical Investigation

Collaboration appears integral to their work, with regular co-authors including:

  • Bernd Jahrsdörfer
  • Carolin Ludwig
  • Sixten Körper
  • Austin Kulasekararaj
  • Eva Schrezenmeier

Best Publications

  • The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.

    Peter Hillmen;Neal S. Young;Jörg Schubert;Robert A. Brodsky

  • SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.

    Markus Hoffmann;Markus Hoffmann;Prerna Arora;Prerna Arora;Rüdiger Groß;Alina Seidel

  • Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria.

    Robert A. Brodsky;Neal S. Young;Elisabetta Antonioli;Antonio M. Risitano

  • Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria.

    Peter Hillmen;Petra Muus;Ulrich Dührsen;Antonio M. Risitano

  • T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells.

    Bernhard Fleischer;Hubert Schrezenmeier

  • CDC42 ACTIVITY REGULATES HEMATOPOIETIC STEM CELL AGING AND REJUVENATION

    Maria Carolina Florian;Karin Dörr;Anja Niebel;Deidre Daria

  • Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group.

    Norbert Frickhofen;Joachim P. Kaltwasser;Hubert Schrezenmeier;Aruna Raghavachar

  • Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men.

    Ernst Späth-Schwalbe;Kirsten Hansen;Frauke Schmidt;Hubert Schrezenmeier

  • Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia

    Norbert Frickhofen;Hermann Heimpel;Joachim P. Kaltwasser;Hubert Schrezenmeier

  • Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria

    Peter Hillmen;Petra Muus;Alexander Roth;Modupe O. Elebute

  • Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).

    Anna Locasciulli;Rosi Oneto;Andrea Bacigalupo;Gerard Socie

  • Mesenchymal stem cells for clinical application.

    L. Sensebe;M. Krampera;Hubert Schrezenmeier;P. Bourin

  • Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study

    Jong Wook Lee;Flore Sicre de Fontbrune;Lily Wong Lee Lee;Viviani Pessoa

  • Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components

    Natalie Fekete;Mélanie Gadelorge;Daniel Fürst;Caroline Maurer

  • A differentiation checkpoint limits hematopoietic stem cell self-renewal in response to DNA damage.

    Jianwei Wang;Qian Sun;Yohei Morita;Hong Jiang

  • Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience.

    Andrea Bacigalupo;Ronald Brand;Rosi Oneto;Barbara Bruno

  • Interleukin 21–Induced Granzyme B–Expressing B Cells Infiltrate Tumors and Regulate T Cells

    S. Lindner;K. Dahlke;K. Sontheimer;M. Hagn

  • Uptake mechanism of oppositely charged fluorescent nanoparticles in HeLa cells.

    Julia Dausend;Anna Musyanovych;Martin Dass;Paul Walther

  • Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells.

    Myriam Ricarda Lorenz;Verena Holzapfel;Anna Musyanovych;Karin Nothelfer

  • Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia.

    Hubert Schrezenmeier;Jakob R. Passweg;Judith C. W. Marsh;Andrea Bacigalupo

Frequent Co-Authors

Gérard Socié
Gérard Socié Université Paris Cité
Jakob Passweg
Jakob Passweg University Hospital of Basel
Andrea Bacigalupo
Andrea Bacigalupo Catholic University of the Sacred Heart
André Tichelli
André Tichelli University Hospital of Basel
Judith C. W. Marsh
Judith C. W. Marsh King's College London
Jeff Szer
Jeff Szer Peter MacCallum Cancer Centre
Régis Peffault de Latour
Régis Peffault de Latour Hôpital Saint-Louis
Jaroslaw P. Maciejewski
Jaroslaw P. Maciejewski Cleveland Clinic
Peter Hillmen
Peter Hillmen St James's University Hospital
klaus schwarz
klaus schwarz University of Ulm

External Links

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to diverse healthcare careers, many of which integrate advanced nursing and clinical specialties. For those interested in entering healthcare quickly, exploring lpn programs with easiest admission requirements can be a practical first step to gain essential patient care skills.

Building on foundational nursing education, registered nurses often seek higher qualifications. The easiest fnp program options provide a streamlined path toward becoming Family Nurse Practitioners, blending clinical expertise with patient-centered care.

For those focused on mental health within the immune system context, specialized programs stand out. The top pmhnp programs offer excellent clinical placements, ensuring valuable hands-on experience for psychiatric-mental health nurse practitioners.

Cost-effective learning is a priority for many students, and identifying the cheapest psychiatric nurse practitioner programs allows aspiring professionals to advance their careers without excessive financial burden.

By understanding these pathways, students can align their Immunology interests with the right online degrees, enhancing career prospects in nursing and allied health fields.

Best Scientists Citing Hubert Schrezenmeier

Trending Scientists

Recently Published Articles